Firstly, the pathological analysis of samples was used to define the breast cancer receptor status as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) positive (+) or negative (−), as well as the histological subtype of the tissue (Table 1). This evidence concerns the gene ESR1 and breast carcinoma.